Enzymatically degradable alginate hydrogel systems to deliver endothelial progenitor cells for potential revasculature applications

Kevin T. Campbell, Roberta S. Stilhano, Eduardo Silva

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

The objective of this study was to design an injectable biomaterial system that becomes porous in situ to deliver and control vascular progenitor cell release. Alginate hydrogels were loaded with outgrowth endothelial cells (OECs) and alginate lyase, an enzyme which cleaves alginate polymer chains. We postulated and confirmed that higher alginate lyase concentrations mediated loss of hydrogel mechanical properties. Hydrogels incorporating 5 and 50 mU/mL of alginate lyase experienced approximately 28% and 57% loss of mass as well as 81% and 91% reduction in storage modulus respectively after a week. Additionally, computational methods and mechanical analysis revealed that hydrogels with alginate lyase significantly increased in mesh size over time. Furthermore, alginate lyase was not found to inhibit OEC proliferation, viability or sprouting potential. Finally, alginate hydrogels incorporating OECs and alginate lyase promoted up to nearly a 10 fold increase in OEC migration in vitro than nondegradable hydrogels over the course of a week and increased functional vasculature in vivo via a chick chorioallantoic membrane (CAM) assay. Overall, these findings demonstrate that alginate lyase incorporated hydrogels can provide a simple and robust system to promote controlled outward cell migration into native tissue for potential therapeutic revascularization applications.

Original languageEnglish (US)
Pages (from-to)109-121
Number of pages13
JournalBiomaterials
Volume179
DOIs
StatePublished - Oct 1 2018

Fingerprint

Hydrogel
Alginate
Endothelial cells
Hydrogels
Endothelial Cells
Cell Movement
Chorioallantoic Membrane
Cell proliferation
Biocompatible Materials
Computational methods
alginic acid
poly(beta-D-mannuronate) lyase
Endothelial Progenitor Cells
Blood Vessels
Assays
Cell Survival
Polymers
Stem Cells
Elastic moduli
Cell Proliferation

Keywords

  • Alginate
  • Cell delivery
  • Endothelial progenitor cells
  • Enzymatically degradable hydrogels
  • Injectable biomaterial
  • Revascularization

ASJC Scopus subject areas

  • Bioengineering
  • Ceramics and Composites
  • Biophysics
  • Biomaterials
  • Mechanics of Materials

Cite this

Enzymatically degradable alginate hydrogel systems to deliver endothelial progenitor cells for potential revasculature applications. / Campbell, Kevin T.; Stilhano, Roberta S.; Silva, Eduardo.

In: Biomaterials, Vol. 179, 01.10.2018, p. 109-121.

Research output: Contribution to journalArticle

@article{a11f317599db415b86c600d8b59e5b0b,
title = "Enzymatically degradable alginate hydrogel systems to deliver endothelial progenitor cells for potential revasculature applications",
abstract = "The objective of this study was to design an injectable biomaterial system that becomes porous in situ to deliver and control vascular progenitor cell release. Alginate hydrogels were loaded with outgrowth endothelial cells (OECs) and alginate lyase, an enzyme which cleaves alginate polymer chains. We postulated and confirmed that higher alginate lyase concentrations mediated loss of hydrogel mechanical properties. Hydrogels incorporating 5 and 50 mU/mL of alginate lyase experienced approximately 28{\%} and 57{\%} loss of mass as well as 81{\%} and 91{\%} reduction in storage modulus respectively after a week. Additionally, computational methods and mechanical analysis revealed that hydrogels with alginate lyase significantly increased in mesh size over time. Furthermore, alginate lyase was not found to inhibit OEC proliferation, viability or sprouting potential. Finally, alginate hydrogels incorporating OECs and alginate lyase promoted up to nearly a 10 fold increase in OEC migration in vitro than nondegradable hydrogels over the course of a week and increased functional vasculature in vivo via a chick chorioallantoic membrane (CAM) assay. Overall, these findings demonstrate that alginate lyase incorporated hydrogels can provide a simple and robust system to promote controlled outward cell migration into native tissue for potential therapeutic revascularization applications.",
keywords = "Alginate, Cell delivery, Endothelial progenitor cells, Enzymatically degradable hydrogels, Injectable biomaterial, Revascularization",
author = "Campbell, {Kevin T.} and Stilhano, {Roberta S.} and Eduardo Silva",
year = "2018",
month = "10",
day = "1",
doi = "10.1016/j.biomaterials.2018.06.038",
language = "English (US)",
volume = "179",
pages = "109--121",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - Enzymatically degradable alginate hydrogel systems to deliver endothelial progenitor cells for potential revasculature applications

AU - Campbell, Kevin T.

AU - Stilhano, Roberta S.

AU - Silva, Eduardo

PY - 2018/10/1

Y1 - 2018/10/1

N2 - The objective of this study was to design an injectable biomaterial system that becomes porous in situ to deliver and control vascular progenitor cell release. Alginate hydrogels were loaded with outgrowth endothelial cells (OECs) and alginate lyase, an enzyme which cleaves alginate polymer chains. We postulated and confirmed that higher alginate lyase concentrations mediated loss of hydrogel mechanical properties. Hydrogels incorporating 5 and 50 mU/mL of alginate lyase experienced approximately 28% and 57% loss of mass as well as 81% and 91% reduction in storage modulus respectively after a week. Additionally, computational methods and mechanical analysis revealed that hydrogels with alginate lyase significantly increased in mesh size over time. Furthermore, alginate lyase was not found to inhibit OEC proliferation, viability or sprouting potential. Finally, alginate hydrogels incorporating OECs and alginate lyase promoted up to nearly a 10 fold increase in OEC migration in vitro than nondegradable hydrogels over the course of a week and increased functional vasculature in vivo via a chick chorioallantoic membrane (CAM) assay. Overall, these findings demonstrate that alginate lyase incorporated hydrogels can provide a simple and robust system to promote controlled outward cell migration into native tissue for potential therapeutic revascularization applications.

AB - The objective of this study was to design an injectable biomaterial system that becomes porous in situ to deliver and control vascular progenitor cell release. Alginate hydrogels were loaded with outgrowth endothelial cells (OECs) and alginate lyase, an enzyme which cleaves alginate polymer chains. We postulated and confirmed that higher alginate lyase concentrations mediated loss of hydrogel mechanical properties. Hydrogels incorporating 5 and 50 mU/mL of alginate lyase experienced approximately 28% and 57% loss of mass as well as 81% and 91% reduction in storage modulus respectively after a week. Additionally, computational methods and mechanical analysis revealed that hydrogels with alginate lyase significantly increased in mesh size over time. Furthermore, alginate lyase was not found to inhibit OEC proliferation, viability or sprouting potential. Finally, alginate hydrogels incorporating OECs and alginate lyase promoted up to nearly a 10 fold increase in OEC migration in vitro than nondegradable hydrogels over the course of a week and increased functional vasculature in vivo via a chick chorioallantoic membrane (CAM) assay. Overall, these findings demonstrate that alginate lyase incorporated hydrogels can provide a simple and robust system to promote controlled outward cell migration into native tissue for potential therapeutic revascularization applications.

KW - Alginate

KW - Cell delivery

KW - Endothelial progenitor cells

KW - Enzymatically degradable hydrogels

KW - Injectable biomaterial

KW - Revascularization

UR - http://www.scopus.com/inward/record.url?scp=85049327140&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85049327140&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2018.06.038

DO - 10.1016/j.biomaterials.2018.06.038

M3 - Article

C2 - 29980073

AN - SCOPUS:85049327140

VL - 179

SP - 109

EP - 121

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

ER -